表紙
市場調査レポート

喘鳴:世界の治験レビュー

Wheezing Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 322172
出版日 ページ情報 英文 69 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
喘鳴:世界の治験レビュー Wheezing Global Clinical Trials Review, H2, 2014
出版日: 2014年12月31日 ページ情報: 英文 69 Pages
概要

当レポートでは、喘鳴の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • 喘鳴
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:呼吸器系疾患の治験における喘鳴の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:呼吸器系疾患の治験における喘鳴の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

喘鳴治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • AstraZeneca PLC
    • Merck & Co., Inc.
    • GlaxoSmithKline plc
    • Amphastar Pharmaceuticals, Inc.
  • 代表的な研究機関・病院の治験の概要
    • Milton S. Hershey Medical Center
    • National Hospital Organization Mie National Hospital
    • University of Massachusetts
    • Albert Einstein College of Medicine of Yeshiva University
    • Case Western Reserve University
    • UMC Utrecht Holding BV
    • Oregon Health & Science University
    • Chinese University of Hong Kong
    • Queen's University
    • University of Calgary

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2519CTIDB

GlobalData's clinical trial report, "Wheezing Global Clinical Trials Review, H2, 2014" provides data on the Wheezing clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Wheezing. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Wheezing. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Wheezing
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of wheezing to Respiratory Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of wheezing to Respiratory Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Wheezing
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in wheezing Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Amphastar Pharmaceuticals, Inc.
      • Clinical Trial Overview of Amphastar Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Milton S. Hershey Medical Center
      • Clinical Trial Overview of Milton S. Hershey Medical Center
      • National Hospital Organization Mie National Hospital
      • Clinical Trial Overview of National Hospital Organization Mie National Hospital
      • University of Massachusetts
      • Clinical Trial Overview of University of Massachusetts
      • Albert Einstein College of Medicine of Yeshiva University
      • Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University
      • Case Western Reserve University
      • Clinical Trial Overview of Case Western Reserve University
      • UMC Utrecht Holding BV
      • Clinical Trial Overview of UMC Utrecht Holding BV
      • Oregon Health & Science University
      • Clinical Trial Overview of Oregon Health & Science University
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
      • Queen's University
      • Clinical Trial Overview of Queen's University
      • University of Calgary
      • Clinical Trial Overview of University of Calgary
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Wheezing Therapeutics, Global, Clinical Trials by Region, 2014*
  • Wheezing Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Wheezing Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Wheezing Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Wheezing Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Wheezing Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Wheezing Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Wheezing Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Wheezing to Respiratory Clinical Trials, G7 Countries (%), 2014*
  • Wheezing Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Wheezing Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Wheezing to Respiratory Clinical Trials, E7 Countries (%), 2014*
  • Wheezing Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Wheezing Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Wheezing Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Wheezing Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Wheezing Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Wheezing Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Wheezing Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Wheezing Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Amphastar Pharmaceuticals, Inc., 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Milton S. Hershey Medical Center, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by National Hospital Organization Mie National Hospital, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Western Reserve University, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2014*
  • Wheezing Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2014*

List of Figures

  • Wheezing Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Wheezing Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Wheezing Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Wheezing Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Wheezing Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Wheezing Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Wheezing Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Wheezing to Respiratory Clinical Trials, G7 Countries (%), 2014*
  • Wheezing Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Wheezing Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Wheezing to Respiratory Clinical Trials, E7 Countries (%), 2014*
  • Wheezing Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Wheezing Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Wheezing Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Wheezing Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Wheezing Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Wheezing Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Wheezing Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top